logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Nazlı Dizman

md anderson cancer center
H指数:24
被引数:2,619

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study

免疫检查点抑制剂再挑战在转移性透明细胞肾细胞癌中的结局：全球真实世界证据研究的结果

ESMO Open
IF8.3
2026-04-210
OAAI
A. Cigliola; B.A. Maiorano; F. Rossari; V. Tateo; C. Mercinelli; N. Dizman; M. Colecchia; F. De Cobelli; A. Larcher; G. Rosiello; A. Briganti; F. Montorsi; U. Capitanio; P.E. Spiess; N. Agarwal; S.K. Pal; A. Necchi
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma

抗体药物偶联物联合疗法在晚期尿路上皮癌中的疗效与安全性

Frontiers in Oncology
IF3.3
2025-10-070
OAAI
Salvador Jaime-Casas; Regina Barragan-Carrillo; Miguel Zugman; Koral Shah; Hedyeh Ebrahimi; Benjamin Mercier; Daniela V. Castro; Peter D. Zang; Alexis LeVee; Wesley Yip; Xiaochen Li; Nazli Dizman; Nicholas J. Salgia; Zeynep Zengin; Luis Meza; JoAnn Hsu; Charles B. Nguyen; Alexander Chehrazi-Raffle; Sumanta K. Pal; Abhishek Tripathi
VHL and TP53 mutation status are not associated with response or progression-free survival in metastatic renal cell carcinoma treated with VEGF-targeted therapies

VHL和TP53突变状态与接受VEGF靶向治疗的转移性肾细胞癌的治疗反应或无进展生存期无关。

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Castro, Daniela; Zugman, Miguel; Zang, Peter; Shah, Koral; Ebrahimi, Hedyeh; Barragan-Carrillo, Regina; Jaime-Casas, Salvador; Mercier, Benjamin; Dizman, Nazli; Salgia, Nicholas; Hsu, Joann; Nguyen, Charles; Yip, Wesley; Chehrazi-Raffle, Alexander; Tripathi, Abhishek; Pal, Sumanta
20Phase II trial of ivonescimab in patients with advanced clear cell renal cell carcinoma previously treated with immune checkpoint blockade: IVORY trial (NCT06940518)

II期临床试验：评估ivonescimab在既往接受过免疫检查点阻断治疗的晚期透明细胞肾细胞癌患者中的疗效（IVORY试验，NCT06940518）。

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Dizman, Nazli; Slack-Tidwell, Rebecca S.; Sheth, Rahul A.; Alhalabi, Omar; Campbell, Matthew T.; Corn, Paul G.; Goswami, Sangeeta; Johns, Andrew; Jonasch, Eric; Lin, John K.; Shah, Amishi Y.; Wang, Jianbo; Zurita-Saavedra, Amado J.; Gao, Jianjun; Tannir, Nizar; Hahn, Andrew W.; Msaouel, Pavlos
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma

转移性肾细胞癌患者中异常替代剪接景观的特征分析

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Mercier, Benjamin; Govindarajan, Ameish; Hansen, Nathaniel; Byron, Sara; Hegde, Apurva; Leskoske, Kristin; Chawla, Neal; Meza, Luis; Zengin, Zeynep; Barragan-Carrillo, Regina; Ebrahimi, Hedyeh; Castro, Daniela; Jaime-Casas, Salvador; Zugman, Miguel; Dizman, Nazli; Hsu, JoAnn; Chehrazi-Raffle, Alexander; Tripathi, Abhishek; Salgia, Nicholas; Pal, Sumanta; Pirrotte, Patrick
Real-World evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: a call for randomized trials

真实世界证据表明，在乳头状肾细胞癌中，当代一线策略并未显示出生存优势：呼吁开展随机试验

ONCOLOGIST
IF4.2
2025-10-010
OA
Zugman, Miguel; Rider, Jennifer R.; Dizman, Nazli; Jaime-Casas, Salvador; Goes, Vitor Abreu; Shah, Koral; Castro, Daniela, V; Mercier, Benjamin; Zang, Peter; Ebrahimi, Hedyeh; Barragan-Carrillo, Regina; Sahu, Diwyanshu; Mandora, Prithviraj Vikramsinh; Hsu, Joann; Yip, Wesley; Nguyen, Charles B.; Chehrazi-Raffle, Alex; Miller, Robert; Powles, Thomas; Choueiri, Toni; Pal, Sumanta K.
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion

晚期尿路上皮癌临床试验的纳入标准：现代化与包容性的评估

CANCER MEDICINE
IF3.1
2025-03-270
OAAI
Mercier, Benjamin D.; Govindarajan, Ameish; Castro, Daniela V.; Li, Xiaochen; Philip, Errol J.; Feng, Matthew I.; Prajapati, Sweta R.; Chan, Elyse H.; Lee, Kyle O.; Sehgal, Ishaan; Patel, Jalen; O'Dell, Anna; Chehrazi-Raffle, Alexander; Ebrahimi, Hedyeh; Rock, Adam; Zengin, Zeynep Busra; Meza, Luis A.; Dizman, Nazli; Hsu, Joann; Liu, Sandy; Dorff, Tanya B.; Pal, Sumanta K.; Tripathi, Abhishek
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

卡博替尼和nivolumab联合或不联合活细菌补充治疗转移性肾细胞癌: 一项随机1期试验

NATURE MEDICINE
IF50
2024-06-285
OAAI
Ebrahimi, Hedyeh; Dizman, Nazli; Meza, Luis; Malhotra, Jasnoor; Li, Xiaochen; Dorff, Tanya; Frankel, Paul; Llamas-Quitiquit, Marian; Hsu, Joann; Zengin, Zeynep B.; Alcantara, Marice; Castro, Daniela; Mercier, Benjamin; Chawla, Neal; Chehrazi-Raffle, Alex; Barragan-Carrillo, Regina; Jaime-Casas, Salvador; Govindarajan, Ameish; Gillece, John; Trent, Jeffrey; Lee, Peter P.; Parks, Thomas P.; Takahashi, Motomichi; Hayashi, Atsushi; Kortylewski, Marcin; Caporaso, J. Gregory; Lee, Keehoon; Tripathi, Abhishek; Pal, Sumanta K.
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy
NUTRIENTS
IF5
2024-05-260
OAAI
Ebrahimi, Hedyeh; Battle, Dena; Salgia, Nicholas J.; Zengin, Zeynep B.; Dizman, Nazli; Meza, Luis; Bergerot, Cristiane D.; Barragan-Carrillo, Regina; Hsu, JoAnn; Castro, Daniela; Mercier, Benjamin; Chawla, Neal; Li, Xiaochen; Tripathi, Abhishek; Liu, Sandy T.; Chehrazi-Raffle, Alex; Vaishampayan, Ulka; Staehler, Michael D.; Pal, Sumanta K.
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy
BJU INTERNATIONAL
IF4.4
2023-09-011
OAAI
Castro, Daniela; Prajapati, Sweta; Feng, Matthew; Chan, Elyse; Lee, Kyle; Paul, Trishita; Sehgal, Ishaan; Patel, Jalen; Li, Xiaochen; Zengin, Zeynep; Ebrahimi, Hedyeh; Govindarajan, Ameish; Meza, Luis; Mercier, Benjamin; Chawla, Neal; Dizman, Nazli; Philip, Errol; Hsu, Joann; Bergerot, Cristiane; Chehrazi-Raffle, Alex; Rock, Adam; Liu, Sandy; Tripathi, Abhishek; Dorff, Tanya; Pal, Sumanta
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles

通过成像质量细胞术表征乳头状和透明细胞肾细胞癌揭示了不同的免疫学特征

FRONTIERS IN IMMUNOLOGY
IF5.9
2023-08-113
OAAI
Govindarajan, Ameish; Salgia, Nicholas J.; Li, Haiqing; Castro, Daniela V.; Mirzapoiazova, Tamara; Armstrong, Brian; Zhao, Dan; Mercier, Benjamin D.; Dizman, Nazli; Chawla, Neal; Zengin, Zeynep; Meza, Luis; Tripathi, Nishita; Sayegh, Nicolas; Chehrazi-Raffle, Alex; Tripathi, Abhishek; Pal, Sumanta K.

研究方向

暂未获取到该数据
S
Sumanta K. Pal
H 指数:88论文数:1,402被引数:3.4万
J
Joann Hsu
H 指数:20论文数:178被引数:2,032
L
Luís Meza
H 指数:25论文数:215被引数:3,456
Z
Zeynep Büşra Zengin
H 指数:14论文数:130被引数:1,102
N
Nicholas Salgia
H 指数:12论文数:85被引数:1,082
D
Daniela V. Castro
H 指数:9论文数:95被引数:303
B
Benjamin Mercier
H 指数:7论文数:72被引数:228
P
Paulo Gustavo Bergerot
H 指数:20论文数:175被引数:2,027
N
Neal Shiv Chawla
H 指数:12论文数:124被引数:1,179
A
Alex Chehrazi‐Raffle
H 指数:16论文数:194被引数:2,499